TWI369984B - Pharmaceutical compositions for treatment of overactive bladder associated with neurological disorders - Google Patents

Pharmaceutical compositions for treatment of overactive bladder associated with neurological disorders

Info

Publication number
TWI369984B
TWI369984B TW094106579A TW94106579A TWI369984B TW I369984 B TWI369984 B TW I369984B TW 094106579 A TW094106579 A TW 094106579A TW 94106579 A TW94106579 A TW 94106579A TW I369984 B TWI369984 B TW I369984B
Authority
TW
Taiwan
Prior art keywords
treatment
pharmaceutical compositions
neurological disorders
overactive bladder
bladder associated
Prior art date
Application number
TW094106579A
Other languages
English (en)
Other versions
TW200533344A (en
Inventor
Yamazaki Yoshinobu
Takuhiro Imamura
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of TW200533344A publication Critical patent/TW200533344A/zh
Application granted granted Critical
Publication of TWI369984B publication Critical patent/TWI369984B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
TW094106579A 2004-03-05 2005-03-04 Pharmaceutical compositions for treatment of overactive bladder associated with neurological disorders TWI369984B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004061476 2004-03-05

Publications (2)

Publication Number Publication Date
TW200533344A TW200533344A (en) 2005-10-16
TWI369984B true TWI369984B (en) 2012-08-11

Family

ID=34918068

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094106579A TWI369984B (en) 2004-03-05 2005-03-04 Pharmaceutical compositions for treatment of overactive bladder associated with neurological disorders

Country Status (9)

Country Link
US (1) US20070167511A1 (zh)
EP (1) EP1724257B1 (zh)
JP (1) JP5004215B2 (zh)
KR (1) KR20070003968A (zh)
CN (1) CN1930123B (zh)
CA (1) CA2557758C (zh)
ES (1) ES2436608T3 (zh)
TW (1) TWI369984B (zh)
WO (1) WO2005085195A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005092321A1 (ja) * 2004-03-24 2005-10-06 Kissei Pharmaceutical Co., Ltd. 頻尿または尿失禁の予防または治療用医薬組成物
KR100965205B1 (ko) * 2004-10-05 2010-06-24 깃세이 야쿠힌 고교 가부시키가이샤 하부요로 폐색 질환에 따른 축뇨장해의 예방 및/또는치료제
PT1806136E (pt) * 2004-10-06 2012-03-08 Kissei Pharmaceutical Composição medicamentosa para a prevenção da transição para o tratamento operatório da hipertrofia prostática
US20080242717A1 (en) * 2007-02-28 2008-10-02 Fumiyasu Sato Methods for treating benign prostatic hyperplasia
JP4497192B2 (ja) 2007-11-08 2010-07-07 船井電機株式会社 光ディスク装置
RU2585727C1 (ru) * 2014-12-12 2016-06-10 Наталья Борисовна Гусева Способ лечения детей с гиперактивным мочевым пузырем

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1432007A (en) 1920-07-09 1922-10-17 Ajax Metal Company Tilting mechanism for furnaces and the like
EP0600675B1 (en) 1992-12-02 1998-07-08 Kissei Pharmaceutical Co., Ltd. Indoline compounds for the treatment of dysuria
US5994294A (en) * 1996-02-02 1999-11-30 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US5932538A (en) * 1996-02-02 1999-08-03 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US20020143007A1 (en) * 1996-02-02 2002-10-03 Garvey David S. Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
US6294517B1 (en) * 1996-02-02 2001-09-25 Nitromed, Inc. Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
AU9095998A (en) 1997-09-22 1999-04-12 Kissei Pharmaceutical Co. Ltd. Remedies for dysuria resulting from prostatic hypertrophy
AU3011299A (en) * 1998-03-23 1999-10-18 Merck & Co., Inc. Combination therapy for the treatment of benign prostatic hyperplasia
US6410554B1 (en) * 1998-03-23 2002-06-25 Merck & Co., Inc. Combination therapy for the treatment of benign prostatic hyperplasia
JP4324266B2 (ja) 1999-02-26 2009-09-02 キッセイ薬品工業株式会社 α１Ａアドレナリン受容体の変異体、当該変異体を用いた測定方法及び前立腺肥大に伴う排尿困難症治療剤
JP2001288115A (ja) * 2001-02-07 2001-10-16 Yamanouchi Pharmaceut Co Ltd 下部尿路症治療剤
UA78854C2 (en) * 2002-09-06 2007-04-25 Kissei Pharmaceutical Crystal for an oral solid drug and oral solid drug for dysuria treatment containing the same
MXPA05006513A (es) * 2002-12-16 2005-09-08 Kissei Pharmaceutical Farmaco solido para uso oral.

Also Published As

Publication number Publication date
EP1724257B1 (en) 2013-11-13
WO2005085195A1 (ja) 2005-09-15
US20070167511A1 (en) 2007-07-19
CA2557758C (en) 2013-09-10
ES2436608T3 (es) 2014-01-03
JPWO2005085195A1 (ja) 2007-12-13
JP5004215B2 (ja) 2012-08-22
EP1724257A4 (en) 2009-10-28
CN1930123B (zh) 2010-06-23
KR20070003968A (ko) 2007-01-05
CA2557758A1 (en) 2005-09-15
EP1724257A1 (en) 2006-11-22
CN1930123A (zh) 2007-03-14
TW200533344A (en) 2005-10-16

Similar Documents

Publication Publication Date Title
IL178730A0 (en) New pharmaceutical compositions for the treatment of sexual disorders ii
GB201001047D0 (en) Methods and compositions for the treatment of neurological disorders
ZA200606804B (en) Pharmaceutical composition for treatment of immunological disorders
TWI369987B (en) New pharmaceutical compositions for the treatment of hyper-proliferative disorders
IL191283A (en) Compositions for treating eye irregularities
ZA200607433B (en) Methods and compositions for the treatment of gastroin-testinal disorders
HK1101140A1 (en) Compositions and methods for treating neurological disorders
IL189622A0 (en) Pharmaceutical compositions for the treatment of inner ear disorders
EP1893216A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES
PL2019683T5 (pl) Podawanie czynników wzrostu do leczenia zaburzeń OUN
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
EP1778341A4 (en) DYNAMIC NERVE STIMULATION FOR THE TREATMENT OF DISEASES
IL177772A0 (en) Methods and compositions for the treatment of gastrointestinal disorders
IL184425A0 (en) Cxcr4 antagonists for the treatment of medical disorders
PL1881823T3 (pl) Kompozycje i sposoby leczenia chorób oczu
WO2008097924A3 (en) Pharmaceutical compositions comprising dextromethorphan analogs for the treatment of neurological disorders
IL190652A0 (en) Novel pharmaceutical combinations for the treatment of respiratory disorders
TWI369984B (en) Pharmaceutical compositions for treatment of overactive bladder associated with neurological disorders
EP1802321A4 (en) COMPOSITIONS AND METHODS FOR MODULATING PGC-1-ALPHA FOR THE TREATMENT OF NEUROLOGICAL DISEASES AND DISORDERS
IL193799A0 (en) New therapeutic combinations for the treatment or prevention of psycotic disorders
ZA200707955B (en) Methods and pharmaceutical compositions for the treatment of neurological damage
ZA200902453B (en) PAI-1 binding modulators for the treatment of ocular disorders
EP2212246B1 (en) TREATMENT OF NEUROLOGICAL DISORDERS
EP2059238A4 (en) THERAPEUTIC COMPOUNDS FOR DISEASES AND DISORDERS
ZA200607463B (en) New pharmaceutical compositions for the treatment of sexual disorders II

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees